IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Haupt Pharma Merger Creates Major CMO Player in Europe

9:24 AM MDT | September 22, 2008 | Deepti Ramesh

The merger of three German contract manufacturers and developers earlier this month to form Haupt Pharma (Berlin) has created a major contract manufacturing organization (CMO) in Europe with eight production facilities, 1,500 employees, and sales of €180 million ($256 million). Invita (Plettenberg, Germany), an investment firm focused on the pharma market, owns the new company, which comprises Amareg (Regensburg), Haupt Pharma (Berlin), and Wülfing Pharma (Gronau). Amareg is mainly focused on cytostatics in film-coated tablet and capsule form as well as...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa